A market growing faster than the rules around it.

Every week, one long conversation with someone shaping the peptide market — researchers, compounding pharmacists, telehealth operators, and the self-experimenters running ahead of the data. Published in full, with complete transcripts.

Free · One email per episode · Unsubscribe anytime

The beat

Regulation

What the FDA's bulks list, the 503A/503B split, and the compounding fights actually mean for anyone trying to build here.

Supply

Where the API comes from, who tests it, and everything that happens between a synthesizer overseas and a patient's refrigerator.

Evidence

What the literature supports, what it doesn't, and how clinicians ended up prescribing well ahead of both.

The gray market

Research-chemical vendors, group buys, and the self-experimenters functioning as an unregulated phase I.

Who’s on

We’re booking season one now. If you work somewhere real in this market and can talk about it plainly, we want the conversation.

Researchers running the trials
Compounding pharmacists
Telehealth and clinic operators
Regulatory and legal
Self-experimenters with real data

Pitch yourself or someone else →